Patients suffering from asbestos-related lung cancer are living longer, healthier lives thanks to breakthrough immune-boosting therapy. The Daily Mail reports results from a trial show the drug, Nivolumab, can help keep the aggressive disease mesothelioma at bay for years. Up to now only seven percent of sufferers lived longer than five years. The cancer is caused by exposure to asbestos, a kind of insulation that was once widely used.